US 11,911,388 B2
TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUGGeneral
US 11,911,388 B2
TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
JEFFREY E RUSSEL
Art Unit:
1654 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
Agent:
Boehringer Ingelheim International GmbH
Inventors:
Eva Ulrike GRAEFE-MODY; Thomas KLEIN; Michael MARK; Hans-Juergen WOERLE
Priority:
10/15/09
Filed:
02/11/21
Granted:
02/27/24
Expiration:
04/11/29
Cooperative Patent Classification (CPC)
A61A61K31/4439A61P3/10A61K